ANDA 78114, held by Bedford. Ciprofloxacin.
As of Nov 15, 2026, ANDA 78114 (Ciprofloxacin In Dextrose 5% In Plastic Container), held by Bedford, was first approved by FDA on Mar 18, 2008, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 18, 2008 | Original application | Approved |
| Ciprofloxacin In Dextrose 5% In Plastic Container200MG/100ML · injectable;injection | Ciprofloxacin | Discontinued |
| Ciprofloxacin In Dextrose 5% In Plastic Container400MG/200ML · injectable;injection | Ciprofloxacin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
